Compare Halozyme Therapeutics Inc. Common Stock (HALO) vs SSR Mining Inc. Common Stock (SSRM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Halozyme Therapeutics Inc. Common Stock vs SSR Mining Inc. Common Stock — how do they compare? Halozyme Therapeutics Inc. Common Stock trades at $110.59 (market cap $12.58B), while SSR Mining Inc. Common Stock trades at $35.43 (market cap $6.83B). The key difference: Halozyme Therapeutics Inc. Common Stock is the larger of the two by market cap, and SSR Mining Inc. Common Stock pays a 0.09% dividend while Halozyme Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Halozyme Therapeutics Inc. Common Stock for 1 Days and SSR Mining Inc. Common Stock for 1 Days on average.
| HALO | SSRM | |
|---|---|---|
Market Cap | $12.58B | $6.83B |
Volume | 2,179,278 | 1,863,519 |
Sector | Health | Basic Materials |
52-Week High | $115.22 | $39.21 |
52-Week Low | $61.63 | $19.48 |
Typical Hold Time | 1 Days | 1 Days |
Enterprise Value | $14.49B | $5.00B |
Dividend Yield | — | 0.09% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Halozyme Therapeutics Inc. Common Stock
Halozyme Therapeutics develops drug-delivery technologies for biopharmaceutical companies. Its ENHANZE technology uses the rHuPH20 enzyme to support subcutaneous delivery of co-administered medicines.
Read more on HALO →About SSR Mining Inc. Common Stock
SSR Mining operates precious-metals mines in the United States, Canada, and Argentina. It produces gold doré and concentrates containing copper, silver, lead, and zinc.
Read more on SSRM →
